期刊文献+

支气管败血波氏杆菌PRN黏附素R1区蛋白的免疫原性 被引量:2

Immunogenicity of Recombinant R1 Region Antigen of Pertactin and Its Efficacy against Bordetella bronchiseptica Challenge
下载PDF
导出
摘要 百日咳杆菌黏附素(PRN)是支气管败血波氏杆菌最重要的保护性抗原。为研究PRN的R1区多肽的免疫原性,分别将prn基因的全长编码区2 040 bp及5′端1 173 bp的片段(prnR1)克隆到原核表达载体pGEX-KG,经IPTG诱导后在大肠杆菌中实现了表达。SDS-PAGE和Western blot检测证实2种表达产物GST-R1和GST-PRN均具有良好的免疫学反应活性。在主动免疫保护试验中,GST-R1和GST-PRN免疫组小鼠均能产生较高的PRN抗体水平;当使用3 LD50的Bb强毒株HH0809进行鼻腔攻毒后,其保护率均为100%(9/9);当使用10 LD50HH0809攻毒时,其保护率分别为33.3%(3/9)和77.8%(7/9)。在被动免疫保护试验中,腹腔免疫GST-R1和GST-PRN兔抗血清均能100%(10/10)保护小鼠抵抗10 LD50HH0809的腹腔攻击,但经PRN吸附后的2种兔抗血清均失去了保护力(0/5)。这些研究结果表明,重组PRN的N端R1区多肽具有良好的免疫原性。 Pertactin(PRN) is identified as one of the most important protective immunogen of Bordetella bronchiseptica(Bb).To study the immunogenicity of region 1(R1) of PRN,the complete coding sequence(2 040 bp) and its 5′-terminal 1 173 bp fragment of the prn gene were separately cloned into the prokaryotic expression vector pGEX-KG,and expressed in the E.coli BL21(DE3) with induction by IPTG.The concentration of purified expression products,glutathione S-transferase(GST)-R1 and GST-PRN were 312.6 and 207.3 μg·mL-1,and the purity of them were 95.2% and 92.4%,respectively.The GST-R1 and GST-PRN showed the similar immunological reactivity in Western-blot analysis.Mice,immunized subcutaneously with two doses of purified GST-R1 or GST-PRN proteins mixed with an equal volume of Freund′s adjuvant,produced robust PRN-specific IgG antibody levels.In these two groups,all 9 mice survived intranasal challenge with three times the 50% lethal dose(LD50) of virulent Bb HH0809,whereas 3 of 9 and 7 of 9 mice survived challenge with ten times LD50,respectively.Furthermore,complete protection(10/10) against intraperitoneal(i.p.) challenge with ten times the LD50 of virulent HH0809 strain was seen in mice that were injected i.p.with 0.5 mL rabbit anti-GST-R1 or anti-GST-PRN serum,whilst there were no survivors in group of mice that received PRN-absorbed rabbit anti-GST-R1(0/5) or anti-GST-PRN serum(0/5).In this study,we have shown that the recombinant GST-R1 protein had strong immunogenicity against Bb infection,which built a good foundation for the further research of highly efficient vaccine against bordetellosis.
出处 《畜牧兽医学报》 CAS CSCD 北大核心 2009年第9期1370-1375,共6页 ACTA VETERINARIA ET ZOOTECHNICA SINICA
基金 河南科技大学博士基金项目(090001337) 国家高技术研究发展计划项目(2006AA10A2062006BAD06A12)
关键词 支气管败血波氏杆菌 百日咳杆菌黏附素 免疫原性 Bordetella bronchiseptica pertactin immunogenicity
  • 相关文献

参考文献12

  • 1BROCKMEIER S L.Prior infection with Bordetella bronchiseptica increases nasal colonization by Haemophilus parasuis in swine[J].Vet Microbiol,2004,99(1):75-78.
  • 2BROCKMEIER S L,LAGER K M.Experimental airborne transmission of porcine reproductive and respiratory syndrome virus and Bordetella bronchiseptica[J].Vet Microbiol,2002,89(4):267-275.
  • 3蔡宝祥.家畜传染病学[M].第4版.北京:中国农业出版社,2008.
  • 4United States Department of Agriculture.Part Ⅱ:reference of swine health and health management in the United States[M].CO:National Animal Health Monitoring System,Fort Collins,2000.
  • 5NOVOTNY P,KOBISCH M,COWNLEY K,et al.Evaluation of Bordetella bronchiseptica vaccines in specific-pathogen free piglets with bacterial cell surface atigens in enzyme-linked immunosorbent assay[J].Infect Immun,1985,50(1):190-198.
  • 6KOBISCH M,NOVOTNY P.Identification of a 68-kilodahon outer membrane protein as the major protective antigen of Bordetella bronchiseptica by using specific-pathogen-free piglets[J].Infect Immun,1990,58(2):352-357.
  • 7ZHAO Z,XUE Y,TANG X B,et al.Vaccination with recombinant protective antigen protects mice against multiple Bordetella bronchiseptica infections[J].Vaccine,2009,57(3):1237-1242.
  • 8GUEIARD P,WEBER C,COUSTUMIER A,et al.Human Bordetella bronchiseptica infection related to contact with infected animals:persistence of bacteria in host[J].J Clin Microbiol,1995,33 (8):2002-2006.
  • 9赵战勤.猪波氏菌病新型基因工程疫苗研究[D].武汉:华中农业大学,2008.
  • 10MATTOO S,CHERRY J D.Molecular pathogenesis,epidemiology,and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies[J].Clin Microbiol Rev,2005,8(2):326-382.

同被引文献16

  • 1裴洁,何华,赵战勤,吴斌.支气管败血波氏杆菌的研究进展[J].畜牧兽医科技信息,2006,22(2):4-6. 被引量:13
  • 2Backstrom L.Present Uses of and Experiences with Swine Vaccines[J].Adv Vet Med,1999,41:419-428.
  • 3United States Department of Agriculture.Part II:Reference of Swine Health and Health Management in the United States[M].CO:National Animal Health Monitoring System,Fort Collins,2000.
  • 4Novotny P,Kobisch M,Cownley K,et al.Evaluation of Bordetella Bronchiseptica Vaccines in Specific-pathogen Free Piglets with Bacterial Cell Surface Atigens in Enzyme-linked Immunosorbent Assay[J].Infect Immun,1985,50(1):190-198.
  • 5Mattoo S,Cherry J D.Molecular Pathogenesis,Epidemiology and Clinical Manifestations of Respiratory Infections Due to Bordetella Pertussis and Other Bordetella Subspecies[J].Clin Microbiol Rev,2005,8(2):326-382.
  • 6Gasteiger E,Hoogland C,Gattiker A,et al.Protein Identification and Analysis Tools on the ExPASy Server[M]//John M Walker.The Proteomics Protocols Handbook.[S.L.]:Humana Press,2005:571-607.
  • 7Zhao Z,Xue Y,Tang X,et al.Immunogenicity of Recombinant Protective Antigen and Efficacy Against Lntranasal Challenge with Bordetella Bronchiseptica[J].Vaccine,2009,27(18):2523-2528.
  • 8Hijnen M,Mooi F R,Gageldonk P G,et al.Epitope Structure of the Bordetella pertussis Protein P.69 Pertactin,a Major Vaccine Component and Protective Antigen[J].Infect Immun,2004,72(7):3716-3723.
  • 9Hijnen M,de Voer R,Mooi F R,et al.The Role of Peptide Loops of the Bordetella Pertussis Protein P.69 Pertactin in Antibody Recognition[J].Vaccine,2007,25(31):5902-5914.
  • 10King A J,Berbers G,Oirschot H F,et al.Role of the Polymorphic Region 1 of the Bordetella Pertussis Protein Pertactin in Immunity[J].Microbiology,2001,147(11):2885-2895.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部